CVS Caremark to cover Zepbound again after lawsuit, widespread backlash

CVS Caremark is adding Zepbound, Eli Lilly’s obesity drug, back to its commercial insurance plan formularies, more than a year after it stopped covering it in favor of Novo Nordisk’s Wegovy.

Vanessa Trump reveals breast cancer diagnosis

Vanessa Trump revealed Wednesday that she has been diagnosed with breast cancer and has started a treatment plan.

Santa Clara University, Sutter Health to open new medical school

The new institution, to be named the Mark and Mary Stevens School of Medicine, will be located in northern Santa Clara near a planned Sutter Health medical complex.

What is the hantavirus from a Stanford Medicine expert
video

Hantavirus is rare and unable to cause a global pandemic, Jorge Salinas, the medical director of infection prevention at Stanford Health Care, expands on what you should know.

Amazon stocking Ozempic pills at kiosks, offering same-day delivery

Amazon is making Ozempic pills more accessible and stocking its U.S. kiosks with the medication and offering same-day delivery.

White House says Trump's drugmaker deals could save economy $529B over next decade

President Trump’s “most favored nation” drugmaker deals could save the economy $529 billion over the next decade, a new White House analysis estimates.

California proposes new licensing path to recruit doctors from Mexico

Assembly Bill 2386 aims to solve the physician shortage by allowing doctors from Mexico to practice in California under provisional licenses.

Clinic workers push back against San Francisco budget cuts

Staff at three community clinics serving youth and seniors in San Francisco are at risk of closing due to budget cuts. The workers there are advocating for their clinics to stay open.

Supreme Court restores abortion pill access

The Supreme Court has restored broad access to the abortion pill mifepristone.

Trump says GLP-1 weight-loss drugs coming at $50 for Medicare patients

President Trump announced the popular GLP-1 weight loss drugs would soon be more accessible to millions of Americans at a cost of only $50 per month.

AI shaping our health care decisions, even whether we go to the doctor

For nearly half of Americans, artificial intelligence plays some sort of role in their health care decisions, a new Gallup poll found. 

FDA approves Foundayo, Eli Lilly's new GLP-1 obesity pill

The U.S. Food and Drug Administration has approved Eli Lilly’s new weight-loss GLP-1 pill, orforglipron, which will be sold as Foundayo.